243 related articles for article (PubMed ID: 24384540)
1. Regulation of hepcidin through GDF-15 in cancer-related anemia.
Jiang F; Yu WJ; Wang XH; Tang YT; Guo L; Jiao XY
Clin Chim Acta; 2014 Jan; 428():14-9. PubMed ID: 24384540
[TBL] [Abstract][Full Text] [Related]
2. Erythropoiesis-driven regulation of hepcidin in human red cell disorders is better reflected through concentrations of soluble transferrin receptor rather than growth differentiation factor 15.
Fertrin KY; Lanaro C; Franco-Penteado CF; de Albuquerque DM; de Mello MR; Pallis FR; Bezerra MA; Hatzlhofer BL; Olbina G; Saad ST; da Silva Araújo A; Westerman M; Costa FF
Am J Hematol; 2014 Apr; 89(4):385-90. PubMed ID: 24860871
[TBL] [Abstract][Full Text] [Related]
3. Hepcidin and GDF-15 are potential biomarkers of iron deficiency anaemia in chronic kidney disease patients in South Africa.
Nalado AM; Olorunfemi G; Dix-Peek T; Dickens C; Khambule L; Snyman T; Paget G; Mahlangu J; Duarte R; George J; Naicker S
BMC Nephrol; 2020 Sep; 21(1):415. PubMed ID: 32993549
[TBL] [Abstract][Full Text] [Related]
4. Growth differentiation factor 15 is related to anemia and iron metabolism in heart allograft recipients and patients with chronic heart failure.
Przybyłowski P; Wasilewski G; Bachorzewska-Gajewska H; Golabek K; Dobrzycki S; Małyszko J
Transplant Proc; 2014 Oct; 46(8):2852-5. PubMed ID: 25380934
[TBL] [Abstract][Full Text] [Related]
5. Growth differentiation factor 15 in anaemia of chronic disease, iron deficiency anaemia and mixed type anaemia.
Theurl I; Finkenstedt A; Schroll A; Nairz M; Sonnweber T; Bellmann-Weiler R; Theurl M; Seifert M; Wroblewski VJ; Murphy AT; Witcher D; Zoller H; Weiss G
Br J Haematol; 2010 Feb; 148(3):449-55. PubMed ID: 19863534
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor 15 increased in severe aplastic anemia patients.
Shao Y; Wang H; Liu C; Cao Q; Fu R; Wang H; Wang T; Qi W; Shao Z
Hematology; 2017 Oct; 22(9):548-553. PubMed ID: 28385068
[TBL] [Abstract][Full Text] [Related]
7. Growth differentiation factor GDF-15 does not influence iron metabolism in stable chronic haemodialysis patients.
Li XY; Ying J; Li JH; Zhu SL; Li J; Pai P
Ann Clin Biochem; 2015 May; 52(Pt 3):399-403. PubMed ID: 25178559
[TBL] [Abstract][Full Text] [Related]
8. Hepcidin in tumor-related iron deficiency anemia and tumor-related anemia of chronic disease: pathogenic mechanisms and diagnosis.
Shu T; Jing C; Lv Z; Xie Y; Xu J; Wu J
Eur J Haematol; 2015 Jan; 94(1):67-73. PubMed ID: 24954786
[TBL] [Abstract][Full Text] [Related]
9. GDF15 is related to anemia and hepcidin in kidney allograft recipients.
Malyszko J; Koc-Zorawska E; Malyszko JS; Glowinska I; Mysliwiec M; Macdougall IC
Nephron Clin Pract; 2013; 123(1-2):112-7. PubMed ID: 23797049
[TBL] [Abstract][Full Text] [Related]
10. Regulation of iron metabolism through GDF15 and hepcidin in pyruvate kinase deficiency.
Finkenstedt A; Bianchi P; Theurl I; Vogel W; Witcher DR; Wroblewski VJ; Murphy AT; Zanella A; Zoller H
Br J Haematol; 2009 Mar; 144(5):789-93. PubMed ID: 19120353
[TBL] [Abstract][Full Text] [Related]
11. Low Serum Hepcidin Levels in Patients with Ulcerative Colitis - Implications for Treatment of Co-existent Iron-Deficiency Anemia.
Ramasamy J; Jagadish C; Sukumaran A; Varghese J; Mani T; Joseph AJ; Simon EG; Jacob M
Inflammation; 2023 Dec; 46(6):2209-2222. PubMed ID: 37486527
[TBL] [Abstract][Full Text] [Related]
12. Serum Hepcidin and GDF-15 levels as prognostic markers in urothelial carcinoma of the upper urinary tract and renal cell carcinoma.
Traeger L; Ellermann I; Wiethoff H; Ihbe J; Gallitz I; Eveslage M; Moritz R; Herrmann E; Schrader AJ; Steinbicker AU
BMC Cancer; 2019 Jan; 19(1):74. PubMed ID: 30646851
[TBL] [Abstract][Full Text] [Related]
13. GDF-15 and Hepcidin Levels in Nonanemic Patients with Impaired Glucose Tolerance.
Yalcin MM; Altinova AE; Akturk M; Gulbahar O; Arslan E; Ors Sendogan D; Yetkin I; Toruner FB
J Diabetes Res; 2016; 2016():1240843. PubMed ID: 27642607
[TBL] [Abstract][Full Text] [Related]
14. Anemia of chronic disease: a unique defect of iron recycling for many different chronic diseases.
Poggiali E; Migone De Amicis M; Motta I
Eur J Intern Med; 2014 Jan; 25(1):12-7. PubMed ID: 23988263
[TBL] [Abstract][Full Text] [Related]
15. Serum hepcidin and growth differentiation factor-15 (GDF-15) levels in polycythemia vera and essential thrombocythemia.
Tarkun P; Mehtap O; Atesoğlu EB; Geduk A; Musul MM; Hacihanefioglu A
Eur J Haematol; 2013 Sep; 91(3):228-235. PubMed ID: 23731455
[TBL] [Abstract][Full Text] [Related]
16. Serum hepcidin-25 in comparison to biochemical markers and hematological indices for the differentiation of iron-restricted erythropoiesis.
Thomas C; Kobold U; Thomas L
Clin Chem Lab Med; 2011 Feb; 49(2):207-13. PubMed ID: 21143009
[TBL] [Abstract][Full Text] [Related]
17. GDF-15 and hepcidin as a therapeutic target for anemia in chronic kidney disease.
Farag NM; Mousa M; Elsayed E; Ismeil A
Ital J Pediatr; 2023 Aug; 49(1):106. PubMed ID: 37649102
[TBL] [Abstract][Full Text] [Related]
18. Hepcidin and hemoglobin content parameters in the diagnosis of iron deficiency in rheumatoid arthritis patients with anemia.
van Santen S; van Dongen-Lases EC; de Vegt F; Laarakkers CM; van Riel PL; van Ede AE; Swinkels DW
Arthritis Rheum; 2011 Dec; 63(12):3672-80. PubMed ID: 22127690
[TBL] [Abstract][Full Text] [Related]
19. Differences in the erythropoiesis-hepcidin-iron store axis between hemoglobin H disease and β-thalassemia intermedia.
Origa R; Cazzola M; Mereu E; Danjou F; Barella S; Giagu N; Galanello R; Swinkels DW
Haematologica; 2015 May; 100(5):e169-71. PubMed ID: 25596269
[No Abstract] [Full Text] [Related]
20. Can Serum Gdf-15 be Associated with Functional Iron Deficiency in Hemodialysis Patients?
Yilmaz H; Cakmak M; Darcin T; Inan O; Bilgic MA; Bavbek N; Akcay A
Indian J Hematol Blood Transfus; 2016 Jun; 32(2):221-7. PubMed ID: 27065587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
